Chief Operations Officer Frank Klein sold 35,558 shares at $66.61 per share, totaling ~$2.4 million.
The transaction involved shares equal to 4% of the executive's total equity stake held before the filing.
This disposition was executed directly through a Rule 10b5-1 trading plan established on September 19, 2025.
Following the transaction, the executive retains a direct position of ~926,000 shares valued at ~$62.52 million as of the August 27, 2026 market close.
Chief Operations Officer Frank Klein reported a sale of 35,558 shares of Rocket Lab Corporation (NASDAQ:RKLB) on Aug. 27, 2026, according to a recent SEC Form 4 filing.
| Metric | Value |
|---|---|
| Transaction value | ~$2.4 million |
| Shares sold | 35,558 |
| Post-transaction shares (directly held) | 925,737 |
| Post-transaction value | ~$62.52 million |
Transaction value based on SEC Form 4 weighted average sale price ($66.61); post-transaction value based on Aug. 27, 2026, market close ($67.53).
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-27) | $67.53 |
| Market Capitalization | $40.4 billion |
| Revenue (TTM) | $769.1 million |
| Net Income (TTM) | -$165.5 million |
Headquartered in Long Beach, California, Rocket Lab is an established aerospace and defense company with 2,600 employees that has built a differentiated market position through integrated launch and spacecraft capabilities. The company generated $769.1 million in TTM revenue while investing significantly in growth and innovation, reflected in its current net loss position. With a market capitalization of $40.4 billion and a year-to-date appreciation of 46.01%, Rocket Lab represents a scaled player in the commercial and government space infrastructure sector.
Frank Klein's sale of Rocket Lab stock appears to have little relation to the stock's performance.
Klein initiated the sale under the Rule 10b5-1 framework back in September. Thus, he avoided the appearance of acting on inside information. Also, since it was just 4% of his holdings, he likely still believes in the company's future.
However, by waiting, he missed the run-up and subsequent sell-off in the stock between April and August. Despite the aforementioned 46% return, he could have significantly increased the profits from his stock sale by selling sooner.
Also, investors have good reason to wonder whether they should follow Klein's lead. The company delayed the launch of its Neutron medium-lift rocket earlier this year. Additionally, the proposed acquisition of Iridium has faced pushback from regulators.
Rocket Lab seems to have a significant overvaluation problem. As a money-losing company, it has no P/E ratio. Still, its price-to-sales (P/S) ratio of 51 gives it a valuation that bears no relationship to the company's performance, suggesting the recent decline in the defense stock's price could continue.
Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.
On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:
Right now, we’re issuing “Double Down” alerts for three incredible companies, available when you join Stock Advisor, and there may not be another chance like this anytime soon.
See the 3 stocks »
*Stock Advisor returns as of August 30, 2026.
Will Healy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Rocket Lab. The Motley Fool has a disclosure policy.